Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period:
Insider Trading Transactions for Lyra Therapeutics Inc.
Goto 0, 1, Next
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
Company Symbol Insider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2022-05-13
Purchase
2022-05-17
5:35 pm
Lyra Therapeutics Inc. LYRA MERRIFIELD C ANN
Director
3,828 $4.829 $18,486 7,328
(Direct)
View
2022-04-12
Purchase
2022-04-14
4:53 pm
Lyra Therapeutics Inc. LYRA PERCEPTIVE ADVISORS LLC
PERCEPTIVE LIFE SCIENCES MASTER FUND LTD
Perceptive LS (A) LLC
EDELMAN JOSEPH
Director
10% Owner
5,924,170 $4.22 $24,999,997 9,146,731
(Indirect)
View
2022-04-12
Purchase
2022-04-14
4:14 pm
Lyra Therapeutics Inc. LYRA NBVM GP LLC
DAMORE RICHARD A
NORTH BRIDGE VENTURE PARTNERS V A LP
NORTH BRIDGE VENTURE PARTNERS V-B LP
North Bridge Venture Partners VI L P
North Bridge Venture Management V L.P.
North Bridge Venture Management VI L.P.
10% Owner
2,369,667 $4.22 $9,999,995 1,318,133
(Indirect)
View
2022-04-12
Purchase
2022-04-14
4:08 pm
Lyra Therapeutics Inc. LYRA ANDERSON EDWARD T
Director
10% Owner
2,488,150 $4.22 $10,499,993 1,436,616
(Indirect
Direct)
View
2022-04-12
Purchase
2022-04-13
7:16 pm
Lyra Therapeutics Inc. LYRA Waksal Harlan
Chairman
236,966 $4.22 $999,997 236,966
(Direct)
View
2021-06-17
Purchase
2021-06-22
4:28 pm
Lyra Therapeutics Inc. LYRA MERRIFIELD C ANN
Director
3,500 $8.9699 $31,395 3,500
(Direct)
View
2020-12-16
Purchase
2020-12-17
4:05 pm
Lyra Therapeutics Inc. LYRA snyderman nancy lynn MD
Director
1,025 $9.72 $9,963 1,025
(Direct)
View
2020-05-05
Purchase
2020-05-29
5:34 pm
Lyra Therapeutics Inc. LYRA PERCEPTIVE ADVISORS LLC
PERCEPTIVE LIFE SCIENCES MASTER FUND LTD
Perceptive LS (A) LLC
EDELMAN JOSEPH
Director
10% Owner
625,000 $16 $10,000,000 3,222,561
(Indirect)
View
2020-05-05
Purchase
2020-05-15
6:16 pm
Lyra Therapeutics Inc. LYRA Soleus Private Equity GP I LLC
Soleus Private Equity Fund I L.P.
Soleus PE GP I LLC
Soleus Capital Master Fund L.P.
Soleus Capital LLC
Soleus Capital Group LLC
Levy Guy
10% Owner
155,000 $16 $2,480,000 155,000
(Indirect)
View
2020-05-05
Sale
2020-05-15
6:16 pm
Lyra Therapeutics Inc. LYRA Soleus Private Equity GP I LLC
Soleus Private Equity Fund I L.P.
Soleus PE GP I LLC
Soleus Capital Master Fund L.P.
Soleus Capital LLC
Soleus Capital Group LLC
Levy Guy
10% Owner
16,909 $16 $270,544 155,000
(Indirect)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
Company Symnbol Insider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2022-03-04
Option Award
2022-03-08
4:26 pm
N/A
2032-03-03
Lyra Therapeutics Inc. LYRA TOBIN JAMES R
Director
14,500 $0 14,500
(Direct)
View
2022-02-16
Option Award
2022-02-18
5:12 pm
N/A
2032-02-15
Lyra Therapeutics Inc. LYRA Palasis Maria
CEO
175,000 $0 175,000
(Direct)
View
2022-02-16
Option Award
2022-02-18
5:09 pm
N/A
2032-02-15
Lyra Therapeutics Inc. LYRA Waksal Harlan
Chairman
520,000 $0 520,000
(Direct)
View
2022-02-12
Option Award
2022-02-15
9:31 pm
N/A
2032-02-11
Lyra Therapeutics Inc. LYRA Noyes Corinne
See Remarks
32,000 $0 32,000
(Direct)
View
2022-02-12
Option Award
2022-02-15
9:31 pm
N/A
2032-02-11
Lyra Therapeutics Inc. LYRA Palasis Maria
CEO
127,400 $0 127,400
(Direct)
View
2022-02-12
Option Award
2022-02-15
9:30 pm
N/A
2032-02-11
Lyra Therapeutics Inc. LYRA Nelson Pamela E.
VP
30,000 $0 30,000
(Direct)
View
2022-02-12
Option Award
2022-02-15
9:30 pm
N/A
2032-02-11
Lyra Therapeutics Inc. LYRA Cavalier Jason
CFO
15,605 $0 15,605
(Direct)
View
2022-02-12
Option Award
2022-02-15
9:30 pm
N/A
2032-02-11
Lyra Therapeutics Inc. LYRA Richard Robert E.
VP
35,000 $0 35,000
(Direct)
View
2021-09-13
Option Award
2021-09-15
5:44 pm
N/A
2031-09-12
Lyra Therapeutics Inc. LYRA Cavalier Jason
CFO
104,000 $0 104,000
(Direct)
View
2021-05-26
Option Award
2021-05-28
6:28 pm
N/A
2031-05-25
Lyra Therapeutics Inc. LYRA ALTMAN MICHAEL SETH
Director
7,250 $0 7,250
(Direct)
View
2021-05-26
Option Award
2021-05-28
6:25 pm
N/A
2031-05-25
Lyra Therapeutics Inc. LYRA Poukalov Konstantin
Director
7,250 $0 7,250
(Direct)
View
2021-05-26
Option Award
2021-05-28
6:24 pm
N/A
2031-05-25
Lyra Therapeutics Inc. LYRA snyderman nancy lynn MD
Director
7,250 $0 7,250
(Direct)
View
2021-05-26
Option Award
2021-05-28
6:24 pm
N/A
2031-05-25
Lyra Therapeutics Inc. LYRA MERRIFIELD C ANN
Director
7,250 $0 7,250
(Direct)
View
2021-05-26
Option Award
2021-05-28
6:23 pm
N/A
2031-05-25
Lyra Therapeutics Inc. LYRA Smith W Bradford
Director
7,250 $0 7,250
(Direct)
View
2021-05-26
Option Award
2021-05-28
6:23 pm
N/A
2031-05-25
Lyra Therapeutics Inc. LYRA ANDERSON EDWARD T
Director
7,250 $0 7,250
(Direct)
View
2021-02-08
Option Award
2021-02-10
4:05 pm
N/A
2031-02-07
Lyra Therapeutics Inc. LYRA Elsey R Don
CFO
45,000 $0 45,000
(Direct)
View
2021-02-08
Option Award
2021-02-10
4:05 pm
N/A
2031-02-07
Lyra Therapeutics Inc. LYRA Palasis Maria
CEO
120,000 $0 120,000
(Direct)
View
2021-02-08
Option Award
2021-02-10
4:05 pm
N/A
2031-02-07
Lyra Therapeutics Inc. LYRA Noyes Corinne
See Remarks
30,000 $0 30,000
(Direct)
View
2021-02-08
Option Award
2021-02-10
4:05 pm
N/A
2031-02-07
Lyra Therapeutics Inc. LYRA Nelson Pamela E.
VP
13,000 $0 13,000
(Direct)
View
2021-02-08
Option Award
2021-02-10
4:05 pm
N/A
2031-02-07
Lyra Therapeutics Inc. LYRA Richard Robert E.
VP
18,000 $0 18,000
(Direct)
View
2020-10-27
Option Award
2020-10-29
8:45 pm
N/A
2030-10-26
Lyra Therapeutics Inc. LYRA snyderman nancy lynn MD
Director
14,500 $0 14,500
(Direct)
View
2020-08-03
Option Award
2020-08-05
4:06 pm
N/A
2030-08-03
Lyra Therapeutics Inc. LYRA Nelson Pamela E.
VP
35,000 $0 35,000
(Direct)
View
2020-06-24
Option Award
2020-06-26
4:18 pm
N/A
2030-06-24
Lyra Therapeutics Inc. LYRA Richard Robert E.
VP
35,000 $0 35,000
(Direct)
View
2020-05-05
Exercise
2020-05-15
6:16 pm
N/A
N/A
Lyra Therapeutics Inc. LYRA Soleus Private Equity GP I LLC
Soleus Private Equity Fund I L.P.
Soleus PE GP I LLC
Soleus Capital Master Fund L.P.
Soleus Capital LLC
Soleus Capital Group LLC
Levy Guy
10% Owner
31,382 $8.63 155,000
(Indirect)
View
2020-05-05
Conversion
2020-05-15
6:16 pm
N/A
N/A
Lyra Therapeutics Inc. LYRA Soleus Private Equity GP I LLC
Soleus Private Equity Fund I L.P.
Soleus PE GP I LLC
Soleus Capital Master Fund L.P.
Soleus Capital LLC
Soleus Capital Group LLC
Levy Guy
10% Owner
15,716,828 $0 155,000
(Indirect)
View
2020-05-05
Exercise
2020-05-15
6:16 pm
2020-01-27
2030-01-27
Lyra Therapeutics Inc. LYRA Soleus Private Equity GP I LLC
Soleus Private Equity Fund I L.P.
Soleus PE GP I LLC
Soleus Capital Master Fund L.P.
Soleus Capital LLC
Soleus Capital Group LLC
Levy Guy
10% Owner
31,382 $0 155,000
(Indirect)
View
2020-04-30
Ownership
2020-05-15
6:13 pm
2020-01-27
2030-01-27
Lyra Therapeutics Inc. LYRA Soleus Private Equity GP I LLC
Soleus Private Equity Fund I L.P.
Soleus PE GP I LLC
Levy Guy
10% Owner
0 $0 31,382
(Indirect)
View
2020-05-05
Exercise
2020-05-06
9:10 pm
N/A
N/A
Lyra Therapeutics Inc. LYRA PERCEPTIVE ADVISORS LLC
PERCEPTIVE LIFE SCIENCES MASTER FUND LTD
Perceptive LS (A) LLC
EDELMAN JOSEPH
Director
10% Owner
480,825 $8.63 1,288,446
(Indirect)
View
2020-05-05
Conversion
2020-05-06
9:10 pm
N/A
N/A
Lyra Therapeutics Inc. LYRA PERCEPTIVE ADVISORS LLC
PERCEPTIVE LIFE SCIENCES MASTER FUND LTD
Perceptive LS (A) LLC
EDELMAN JOSEPH
Director
10% Owner
84,310,584 $0 1,288,446
(Indirect)
View
2020-05-05
Exercise
2020-05-06
9:10 pm
2020-01-17
2030-01-10
Lyra Therapeutics Inc. LYRA PERCEPTIVE ADVISORS LLC
PERCEPTIVE LIFE SCIENCES MASTER FUND LTD
Perceptive LS (A) LLC
EDELMAN JOSEPH
Director
10% Owner
480,825 $0 1,288,446
(Indirect)
View
2020-05-05
Tax Withholding
2020-05-06
9:10 pm
N/A
N/A
Lyra Therapeutics Inc. LYRA PERCEPTIVE ADVISORS LLC
PERCEPTIVE LIFE SCIENCES MASTER FUND LTD
Perceptive LS (A) LLC
EDELMAN JOSEPH
Director
10% Owner
259,346 $16 1,288,446
(Indirect)
View
Goto 0, 1, Next